Cat.No - DR-CO-E0009 Size - 50T Price - 20475
Cat.No - DR-CO-E0005 Size - 40T Price - 20475
Cat.No - DR-CO-E0010 Size - 50T Price - 20475
Cat.No - DR-CO-E0008 Size - 50T Price - 20475
Taq DNA Polymerase Carmine Taq PCR Master Mix (With Dye) 2X Taq PCR Smart Mix without dye
2X Real-Time PCR Master Mix including SYBR Green in Mixture 2X HRM Master mix
cDNA synthesis Kit cDNA synthesis Kit with RNase inhibitor OneStep RT-PCR Smart Mix
The FactView Vitamin D Rapid Test Device is a diagnostic assay used for the qualitative detection of Vitamin D levels in blood samples. Here's more information about this type of diagnostic test: Purpose: The test is used for the rapid detection of Vitamin D deficiency or insufficiency. Vitamin D is essential for bone health, immune function, and various other physiological processes in the body. Principle: The FactView Vitamin D Rapid Test Device is typically an immunochromatographic assay that detects the presence of Vitamin D in a patient's blood sample. The test device contains specific antibodies or receptors that bind to Vitamin D molecules, leading to the formation of visible test lines. Components: The test kit usually includes test cassettes, sample droppers, buffer solutions, and desiccants. The test cassettes contain pre-coated membranes with specific reagents for capturing Vitamin D molecules. Procedure: The test procedure involves collecting a small amount of blood from the patient (usually obtained via finger prick) and applying it to the sample well of the test cassette. Buffer solution is then added, allowing the blood sample to migrate along the test strip. Results are typically visible within a few minutes. Interpretation: The appearance of colored lines on the test strip indicates the presence or absence of Vitamin D in the blood sample. A visible line in the control region indicates that the test is valid. Additional lines in the test region(s) indicate positive results for Vitamin D. Sensitivity and Specificity: The FactView Vitamin D Rapid Test Device demonstrates sensitivity and specificity for detecting Vitamin D levels within a certain range. However, like all diagnostic tests, false-positive and false-negative results are possible and should be interpreted in conjunction with clinical findings. Utility: The rapid detection of Vitamin D levels provides valuable information for assessing Vitamin D status, identifying deficiency or insufficiency, and guiding patient management decisions. Vitamin D deficiency is associated with various health problems, including bone disorders, immune dysfunction, and increased risk of certain diseases. Limitations: While rapid diagnostic tests are useful for Vitamin D screening, they have limitations compared to more accurate laboratory methods such as liquid chromatography-mass spectrometry (LC-MS). Factors such as test sensitivity, specificity, and the influence of interfering substances can affect test performance. Overall, the FactView Vitamin D Rapid Test Device is a convenient tool for assessing Vitamin D levels, allowing for timely intervention and management of Vitamin D-related health conditions. However, results should be interpreted carefully in conjunction with clinical evaluation and other laboratory tests.
"FactView Malaria Rapid PF/PV" likely refers to a diagnostic test for the rapid detection of Plasmodium falciparum (PF) and Plasmodium vivax (PV), two species of malaria parasites. Here's more information about this type of diagnostic test: Purpose: The FactView Malaria Rapid PF/PV test is used for the rapid detection of malaria infection caused by the Plasmodium falciparum and Plasmodium vivax parasites. Malaria is a serious infectious disease transmitted by the bite of infected Anopheles mosquitoes. Principle: The test is based on immunochromatographic principles, where specific antibodies are used to detect the presence of malaria antigens in a patient's blood sample. The presence of the PfHRP2 antigen indicates P. falciparum infection, while the presence of the pLDH antigen indicates P. vivax infection. Components: The FactView Malaria Rapid PF/PV test typically includes test cassettes, sample droppers, buffer solutions, and desiccants. The test cassettes contain pre-coated membranes with specific antibodies for detecting malaria antigens. Procedure: The test procedure involves collecting a small amount of blood from the patient (usually obtained via finger prick) and applying it to the sample well of the test cassette. Buffer solution is then added, allowing the blood sample to migrate along the test strip. Results are typically visible within 15-20 minutes. Interpretation: The appearance of colored lines on the test strip indicates the presence or absence of malaria antigens. A visible line in the control region indicates that the test is valid. Additional lines in the test regions indicate positive results for P. falciparum and/or P. vivax antigens. Sensitivity and Specificity: The FactView Malaria Rapid PF/PV test demonstrates high sensitivity and specificity for detecting malaria infections caused by P. falciparum and P. vivax parasites. However, like all diagnostic tests, false-positive and false-negative results are possible and should be interpreted in conjunction with clinical findings. Utility: Rapid diagnostic tests like the FactView Malaria Rapid PF/PV provide a quick and convenient method for diagnosing malaria infections in resource-limited settings, where access to laboratory facilities and microscopy may be limited. Limitations: While rapid diagnostic tests are valuable tools for malaria diagnosis, they have limitations compared to more sensitive methods such as microscopy or molecular testing. Factors such as test storage conditions, operator technique, and the stage of infection can influence test performance.
Cat No : RK081-25. Ulta Covid-19 Ag test is a rapid Immunochromatographic assey for the qualitative detection of specific antigens to SAR-COV-2 present in human nasopharynx.
CAT No : Q-NCOV-01G. STANDARD Q COVID-19 Antigen Test kit is chromatographic immunoassay for the qualitative detection of SARS CoV 2 nucleocapsid antigen present in human nasal sample.
CAT No : RK055-25. STANDARD Q COVID-19 Ag is a rapid Immunochromatographic assay for the qualitative detection of specific antigens to SARS-CoV-2 present in human nasopharynx. Qualitatively detects specific antigens to SARS-CoV-2 present in Human Nasopharynx. The test should be used as an aid in early diagnosis of symptomatic cases in healthcare setting having ILI. Validated by ICMR & AIIMS Sensitivity of 84.38 % & Specificity of 100% Sample Type- Human Nasopharyngeal swab (No other sample recommended) Results in 15-30 mins
ImmunoQuick Covid-19 IgM/IgG Test : Covid-19 or commonly known as Coronavirus is a viral infection involving a patients upper respiratory tract. It is highly contagious and causes a severe lung infection which can be severely debilitating and sometimes fatal. Our test detects two types of antibodies to Covid-19 which appear from 2 to 21 days after infection. It is an invaluable test to diagnose people who have been sick for a few days or those who have recovered. Salient Features of the Product It is rapid immunoassay for qualitative detection of Covid-19 IgM and IgG antibodiesin Human Serum or Plasma or Whole Blood. Results available in 15 minutes. Sensitivity :: >96% Specificity :: >99% No cross reactivity observed. Can be stored at 4 to 30C Stable for 24 months. Pack size :: 25 tests.
CAT No : 41FK51. The Panbio COVID-19 Antigen Self-Test is a single-use, in vitro (outside the body) visually read rapid immunoassay that uses a human nasal swab specimen for the qualitative detection of nucleocapsid protein SARS-CoV-2 antigen. The test can determine if you have an active COVID-19 infection and you will know your test results in just 15 minutes Only Proven High-Accuracy Self-Test in India In clinical evaluations with self-test users, the Panbio COVID-19 Antigen Self-Test correctly identified 100% of negative samples and 95.2% of Positive Samples Pregnancy had no impact on the performance of the test.
Cat. No : COVAG025-1.The GenBody COVID-19 Ag is an immunochromatographic rapid diagnostic test (RDT) intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct nasopharyngeal (NP) oranteriornasal (AN) swab specimens from individuals who are suspected of COVID-19 by their healthcare provider within the first six days of symptom onset.
CAT No : SS03P25. Sure Status COVID-19 Antigen Card Test is a rapid chromatographic immunoassay for the qualitative detection of specific antigens to SARS-CoV-2 present in human nasopharynx.
Cat. No : 601430050. Truenat COVID-19 Chip-based Real Time PCR Test is a semi quantitative detection of SARS CoV-2 RNA in human oropharyngeal and nasopharyngeal swab specimen and aids in detection and confirmation of SARS CoV-2 infection and diagnosis of COVID-19. The test detects the E and Orf1a genes of the virus. Providing you the best range of Molbio Trueprep Auto Universal Cartridge Based Sample Prep Device, Molbio Trueprep AUTO Universal Cartridge Based Sample Prep Kit, Molbio Trueprep AUTO MTB Sample Pre Treatment Pack Kit, Molbio Trueprep AUTO Universal Sample Pre-treatment Pack and Molbio Trueprep AUTO Transport Medium for Swab Specimen Pack with effective & timely delivery.
The Acculaâ?¢ System from Thermo Fisher Scientific is a rapid diagnostic platform that combines the accuracy of RT-PCR with the simplicity, convenience, and procedural familiarity of traditional rapid immunoassays. The Acculaâ?¢ SARS-CoV-2 Test has received an Emergency Use Authorization (EUA) from the FDA for the detection of SARS-CoV-2 in Clinical Laboratory Improvement Amendments (CLIA) waived environments. Designed for use with the palm-sized Accula Dock, the Accula SARS-CoV-2 Test provides reliable, qualitative results in approximately 30 minutes
Pathodetect 2019- nCov Detectioin kit offer an in virto diagnostic real time PCR assay for qualitative detection of 2019 - Novel Coronavirus RNA in respiratory specimens and sera. The kit offer the universal detection of SARS- Like coronavirus and specific detection of 2019-nCOv. Mylab Discovery solutions 2019-nCoV Detection Kit provides ready to use solution for detection of coronavirus using real time PCR technology. Detection is based on the amplification of a specific conserved RNA sequences of coronavirus and detection by Taqman probe-based chemistry. An Internal control is detected along with the coronavirus target controlling the extraction efficacy and possible PCR inhibition. The test is designed to use across wide range of PCR platforms. The recommended CDC protocol for coronavirus detection ensures that the kit leads to highly-specific and ultrasensitive results in short time. KIT CONTENTS Reagents for Nucleic acid extraction from respiratory/sera specimens Reagents for Real time PCR Inclusion of synthetic positive and negative controls
Cat No : RP10243X. Detection of COVID-19 specific target genes in a single tube- Reliable result with three target genes- Results within 1 hour and 50 minutes after extraction- Convenient work now on the automated MDx platform- Suitable for high-throughput- Providing whole process control for assay validity- Automated data interpretation with Seegene Viewer.
